China Pediatric Pharmaceuticals (CPDU) Inventory Turnover Ratio, from first quarter 2014 to first quarter 2013, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
China Pediatric Pharmaceuticals, Inc.  (CPDU)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

China Pediatric Pharmaceuticals Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

China Pediatric Pharmaceuticals, Inc. inventory turnover ratio, the China Pediatric Pharmaceuticals, Inc.'s ability to sell and replace its inventory in the first quarter 2014, sequentially increased to 8.17 in the first quarter 2014, CPDU's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the China Pediatric Pharmaceuticals in Mar 31 2014 quarter, has decreased to 45 days, compare to 69 days, in the Dec 31 2013 quarter.

Within Healthcare sector 39 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2014, to 506, from total ranking in the fourth quarter 2013 at 781.

CPDU Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is China Pediatric Pharmaceuticals, Inc. Market Share?

What is Inventory Turnover Ratio?




CPDU Inventory Turnover Ratio (Mar 31 2014)
I. Quarter
(Dec 31 2013)
IV. Quarter
(Sep 30 2013)
III. Quarter
(Jun 30 2013)
II. Quarter
(Mar 31 2013)
I. Quarter
Y / Y Inventory Growth -73.71 % -93.1 % -87.7 % -75.63 % -70.49 %
Y / Y Cost of Sales Growth 72.82 % -92.34 % -52.1 % -84.81 % -96.13 %
Inventory Turnover Ratio (TTM) 8.17 5.26 11.2 6.87 6.75
CPDU's Total Ranking # 506 # 781 # 503 # 583 # 503
Average inventory processing period 45 69 33 53 54
Seq. Inventory Growth 0.47 % -60.02 % -41.82 % 12.5 % -73.62 %
Seq. Cost of Sales Growth 40.83 % 42.82 % -15.96 % 2.24 % -93.76 %




Inventory Turnover Ratio Company Ranking
Within: No.
Healthcare Facilities Industry # 10
Healthcare Sector # 40
Overall Market # 506

Inventory Turnover Ratio Statistics
High Average Low
11.46 7.78 5.26
(Dec 31 2012)   (Dec 31 2013)




Financial Statements
China Pediatric Pharmaceuticals's Inventories $ 0 Millions Visit CPDU's Balance sheet
China Pediatric Pharmaceuticals's Cost of Revenues TTM $ 1 Millions Visit CPDU's Income Statement
What are CPDU's Sales? Visit CPDU's Sales by Segment

Other Inventory Turnover Ratios
China Pediatric Pharmaceuticals's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Healthcare Facilities Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CPDU's Inventory Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CPDU's Competitors
Inventory Turnover Ratio for CPDU's Suppliers
Inventory Turnover Ratio for CPDU's Customers

You may also want to know
CPDU's Sales Growth Rates CPDU's Pe Price to earnings ratio CPDU's Receivables Turnover Ratio CPDU's Stock Quote
CPDU's Net Income Growth Rates CPDU's Ps Price to Sales ratio CPDU's Sales per Employee CPDU's Asset Turnover Ratio
CPDU's Net Margin CPDU's Pb Price to Book ratio CPDU's Financial Strength Ratios CPDU's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2014, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2014 Inventories at quarter ending Mar 31 2014
Labcorp Holdings Inc   48.11 $ 6,304.500  Millions$ 131  Millions
Quest Diagnostics Inc  47.56 $ 4,335.163  Millions$ 91  Millions
Ethema Health Corporation   45.51 $ 0.961  Millions$ 0  Millions
Heartbeam Inc   41.20 $ 129.989  Millions$ 3  Millions
China Health Industries Holdings Inc   39.24 $ 23.328  Millions$ 1  Millions
Healthcare Services Group Inc   33.02 $ 1,027.284  Millions$ 31  Millions
Jazz Pharmaceuticals Plc  29.44 $ 873.423  Millions$ 30  Millions
Hca Healthcare Inc   21.96 $ 25,545.000  Millions$ 1,163  Millions
Veracyte Inc   19.97 $ 38.598  Millions$ 2  Millions
Option Care Health Inc   19.44 $ 609.048  Millions$ 31  Millions
Zeo Scientifix Inc   19.40 $ 0.278  Millions$ 0  Millions
Bioxytran Inc   18.21 $ 0.267  Millions$ 0  Millions
Insulet Corporation  17.75 $ 138.835  Millions$ 8  Millions
Lisata Therapeutics Inc   17.39 $ 14.381  Millions$ 1  Millions
Rockwell Medical inc   16.07 $ 45.949  Millions$ 3  Millions
Rayont Inc   15.60 $ 0.688  Millions$ 0  Millions
Biolife Solutions Inc   15.33 $ 6.595  Millions$ 0  Millions
Immunogen inc   15.29 $ 30.060  Millions$ 2  Millions
Vaso Corporation  13.80 $ 26.449  Millions$ 2  Millions
Fonar Corporation  13.75 $ 31.891  Millions$ 2  Millions
Clearday Inc   13.50 $ 1.195  Millions$ 0  Millions
Adm Tronics Unlimited Inc   12.64 $ 2.198  Millions$ 0  Millions
Windtree Therapeutics Inc  11.85 $ 1.298  Millions$ 0  Millions
Align Technology inc   11.26 $ 169.349  Millions$ 15  Millions
Fibrocell Science, Inc.  11.07 $ 6.357  Millions$ 1  Millions
Perspective Therapeutics Inc   10.84 $ 4.429  Millions$ 0  Millions
Henry Schein Inc   10.23 $ 12,069.342  Millions$ 1,180  Millions
Bohai Pharmaceuticals Group, Inc.  9.99 $ 42.569  Millions$ 4  Millions
Medifirst Solutions, Inc.  9.16 $ 0.057  Millions$ 0  Millions
Ufp Technologies Inc   9.03 $ 99.359  Millions$ 11  Millions

Date modified: 2026-10-07T00:41:26+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.